Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis

References

• Manolagas SC, Jilka RL, Epstein FH. Bone marrow, cytokines, and bone remodeling-emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332(5):305–311. doi:10.1056/NEJM1995020233205067816067
   PubMed Web of Science ®Google Scholar
• Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99–107. doi:10.1080/03008207.2017.129008528324674
   PubMed Web of Science ®Google Scholar
• Black DM, Rosen CJ, Solomon CG. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2016;374(3):254–262. doi:10.1056/NEJMcp151372426789873
   PubMed Web of Science ®Google Scholar
• Klibanski A, Campbell LA, Bassford T, et al. NIH consensus development panel on osteoporosis prevention D, therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–795. doi:10.1001/jama.285.6.78511176917
   PubMed Web of Science ®Google Scholar
• Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508–1514. doi:10.1126/science.289.5484.150810968781
   PubMed Web of Science ®Google Scholar
• Goldberg MF, Roeske EK, Ward LN, et al. Salmonella persist in activated macrophages in T cell-sparse granulomas but are contained by surrounding CXCR3 ligand-positioned Th1 cells. Immunity. 2018;49(6):1090–102.e7. doi:10.1016/j.immuni.2018.10.00930552021
   PubMed Web of Science ®Google Scholar
• Huang B, Wang W, Li Q, et al. Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone. Nat Commun. 2016;7:13885. doi:10.1038/ncomms1388527966526
   PubMed Web of Science ®Google Scholar
• Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014;507(7492):323–328. doi:10.1038/nature1314524646994
   PubMed Web of Science ®Google Scholar
• Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial notch activity promotes angiogenesis and osteogenesis in bone. Nature. 2014;507(7492):376–380. doi:10.1038/nature1314624647000
   PubMed Web of Science ®Google Scholar
• Li J-Y, Tawfeek H, Bedi B, et al. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A. 2011;108(2):768–773. doi:10.1073/pnas.101349210821187391
   PubMed Web of Science ®Google Scholar
• Rao LG, Ng B, Brunette DM, Heersche JN. Parathyroid hormone- and prostaglandin E1-response in a selected population of bone cells after repeated subculture and storage at −80C. Endocrinology. 1977;100(5):1233–1241. doi:10.1210/endo-100-5-1233191237
   PubMed Web of Science ®Google Scholar
• Bhargava U, Bar-Lev M, Bellows CG, Aubin JE. Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone. 1988;9(3):155–163. doi:10.1016/8756-3282(88)90005-13166832
   PubMed Web of Science ®Google Scholar
• Lee SE, Chung WJ, Kwak HB, et al. Tumor necrosis Factor-α supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem. 2001;276(52):49343–49349. doi:10.1074/jbc.M10364220011675379
   PubMed Web of Science ®Google Scholar
• Kwak HB, Lee SW, Jin HM, et al. Monokine induced by interferon- is induced by receptor activator of nuclear factor B ligand and is involved in osteoclast adhesion and migration. Blood. 2005;105(7):2963–2969. doi:10.1182/blood-2004-07-253415585657
   PubMed Web of Science ®Google Scholar
• Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007;130(5):811–823. doi:10.1016/j.cell.2007.07.02517803905
   PubMed Web of Science ®Google Scholar
• Jinquan T, Quan S, Jacobi HH, et al. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood. 2000;96(4):1230–1238.10942362
   PubMed Web of Science ®Google Scholar
• Bonacchi A, Romagnani P, Romanelli RG, et al. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem. 2001;276(13):9945–9954. doi:10.1074/jbc.M01030320011136732
   PubMed Web of Science ®Google Scholar
• Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest. 2002;110(11):1643–1650. doi:10.1172/JCI021568712464669
   PubMed Web of Science ®Google Scholar
• Xiao W, Wang Y, Pacios S, Li S, Graves DT. Cellular and molecular aspects of bone remodeling. Front Oral Biol. 2016;18:9–16.26599113
   PubMedGoogle Scholar
• Matsuo K, Irie N. Osteoclast–osteoblast communication. Arch Biochem Biophys. 2008;473(2):201–209. doi:10.1016/j.abb.2008.03.02718406338
   PubMed Web of Science ®Google Scholar
• Tamma R, Zallone A. Osteoblast and osteoclast crosstalks: from OAF to Ephrin. Inflamm Allergy Drug Targets. 2012;11(3):196–200. doi:10.2174/18715281280039267022280242
   PubMedGoogle Scholar
• Nakahama K-I. Cellular communications in bone homeostasis and repair. Cell Mol Life Sci. 2010;67(23):4001–4009. doi:10.1007/s00018-010-0479-320694737
   PubMed Web of Science ®Google Scholar
• Sims NA, Walsh NC. Intercellular cross-talk among bone cells: new factors and pathways. Curr Osteoporos Rep. 2012;10(2):109–117. doi:10.1007/s11914-012-0096-122427140
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim H-N, Kim K-O, et al. CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Cancer Res. 2012;72(13):3175–3186. doi:10.1158/0008-5472.CAN-12-048122562465
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim B, Jin WJ, Kim -H-H, Ha H, Lee ZH. Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis. Arthritis Res Ther. 2017;19(1):163. doi:10.1186/s13075-017-1353-628724396
   PubMed Web of Science ®Google Scholar
• Matic I, Matthews BG, Wang X, et al. Quiescent bone lining cells are a major source of osteoblasts during adulthood. Stem Cells. 2016;34(12):2930–2942. doi:10.1002/stem.247427507737
   PubMed Web of Science ®Google Scholar
• Hanaoka H. The origin of the osteoclast. Clin Orthop Relat Res. 1979;(145):252–263.394900
   PubMed Web of Science ®Google Scholar
• Pacifici R. Role of T cells in ovariectomy induced bone loss–revisited. J Bone Miner Res. 2012;27(2):231–239. doi:10.1002/jbmr.150022271394
   PubMed Web of Science ®Google Scholar
• Cline-Smith A, Axelbaum A, Shashkova E, et al. Ovariectomy activates chronic low-grade inflammation mediated by memory T cells, which promotes osteoporosis in mice. J Bone Miner Res. 2020. doi:10.1002/jbmr.3966
   Web of Science ®Google Scholar
• Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One. 2012;7(9):e44552. doi:10.1371/journal.pone.004455222970248
   PubMed Web of Science ®Google Scholar
• Wang T, Liu Q, Tjhioe W, et al. Therapeutic potential and outlook of alternative medicine for osteoporosis. Curr Drug Targets. 2017;18(9):1051–1068. doi:10.2174/138945011866617032110542528325144
   PubMed Web of Science ®Google Scholar
• Gennari L, Rotatori S, Bianciardi S, Nuti R, Merlotti D. Treatment needs and current options for postmenopausal osteoporosis. Expert Opin Pharmacother. 2016;17(8):1141–1152. doi:10.1080/14656566.2016.117614727055223
   PubMed Web of Science ®Google Scholar
• Anastasilakis AD, Polyzos SA, Makras P. THERAPY OF ENDOCRINE DISEASE: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis. Eur J Endocrinol. 2018;179(1):R31–R45. doi:10.1530/EJE-18-005629691303
   PubMed Web of Science ®Google Scholar
• Shibahara T. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ): a twist of fate in the bone. Tohoku J Exp Med. 2019;247(2):75–86. doi:10.1620/tjem.247.7530713280
   PubMed Web of Science ®Google Scholar
• Lems WF, Saag K. Bisphosphonates and glucocorticoid-induced osteoporosis: cons. Endocrine. 2015;49(3):628–634. doi:10.1007/s12020-015-0639-126041376
   PubMed Web of Science ®Google Scholar